Skip to main content
Glama

Read who signs an application bundle's applications

payer_follow_up_signers
Read-onlyIdempotent

Application bundle: read who signs each clinician's written applications, with the account ID and the access token. For each clinician whose applications we write: the signer's name, their email and mobile number with most characters hidden, where the signing stands (nothing to sign yet, waiting for the signer's contact, link sent, opened, signed, or what stopped it), and when the clinician confirmed the email or mobile is their own. Only the clinician signs, from their own phone or computer, after a one-time code.

Input Schema

NameRequiredDescriptionDefault
account_idYesThe account_id payer_follow_up_request returned.
access_tokenYesThe access_token payer_follow_up_request returned (shown once), or the token in an emailed link.

Schema Changelog

Changes observed during successful MCP inspections.

  1. Added

TDQS

A3.7/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly, idempotent, non-destructive and closed-world, so the bar is lower. The description still earns credit by disclosing what comes back: masked email/mobile, the full set of signing states (nothing to sign yet, awaiting contact, link sent, opened, signed, or what stopped it), and the one-time-code/own-device constraint on who signs.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Front-loaded with the core read action, and the following enumeration of returned fields and signing states is dense but each item carries information. The long trailing state list is somewhat sprawling compared with the crisp opening, keeping it just short of a 5.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description must describe returns, and it does so thoroughly: signer name, masked contact, signing state, and confirmation timing. Combined with annotations covering the safety profile and a fully documented 2-param schema, an agent has what it needs to call it correctly; only the lack of failure/empty-case behavior keeps it from 5.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so both account_id and access_token are already documented as coming from payer_follow_up_request to a high standard. The description only restates that the account ID and access token are needed, adding no format or sourcing detail beyond the schema; baseline 3 applies.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

Names a specific verb and resource: read who signs each clinician's written applications within an application bundle. It is clearly a read operation distinct from the write-flavored sibling payer_follow_up_signer_set, but the description never names that sibling or explicitly contrasts the two, so differentiation is inferred from the name rather than stated.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Usage is only implied: an agent can infer this is the read-path for checking signer identity and signing progress versus the set path. There is no explicit when-to-use/when-not-to-use statement and no named alternative (e.g., payer_follow_up_status or payer_follow_up_signer_set) to route between.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources